Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Shares withheld for taxes President and CEO gave up 139,524 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Research and Development gave up 27,254 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, Commercial gave up 32,332 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP and CFO gave up 40,459 shares (to pay taxes)
  5. 4 Grant or award SVP and General Counsel acquired 30,170 shares (grant or award)
  6. 4 Open-market buy Director bought 27,532 shares at $43.12 ($1,187,235)
  7. 4 Open-market sale EVP, Commercial sold 72,230 shares at an average $42.18 ($3,046,928)
  8. 4 Gift EVP, Research and Development gave 24,000 shares (gift)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Gift Director gave 1,044 shares (gift)
  11. 4 Open-market sale Director sold 100,000 shares at $43.55 ($4,355,000)
  12. 4 Gift President and CEO gave 341,548 shares (gift)
  13. 4 Open-market sale EVP, Research and Development sold 48,383 shares at $42.50 ($2,056,278)
  14. 4 Open-market sale Director sold 24,622 shares at an average $41.93 ($1,032,414)
  15. 4 Grant or award EVP, Research & Development acquired 50,673 shares (grant or award)
  16. 4 Planned sale Director sold 18,838 shares at an average $42.74 ($805,140)
  17. 4 Planned sale Director sold 7,535 shares at $43.09 ($324,683)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 9,812 shares (grant or award)
  20. 4 Grant or award Director acquired 9,812 shares (grant or award)

Page 3 of 73 · 1,458 filings